Travel support 2020 Zurich February
| Reference number | |
| Coordinator | ONCORENA AB |
| Funding from Vinnova | SEK 15 000 |
| Project duration | January 2020 - February 2020 |
| Status | Completed |
Important results from the project
** Denna text är maskinöversatt ** ONCORENA needs to make a Series A investment to fund the company from the beginning of clinical development for 3 years. Vid SWISS Nordic Investor Meeting in Zurich, Switzerland organized by Business Sweden, we have had the opportunity to discuss Oncorena´s project with potential Swiss and other international investors. The purpose of the meeting has been fulfilled: We During the meeting, we met with a number of new potential investors and we will also have follow-up discussions.
Expected long term effects
** Denna text är maskinöversatt ** ONCORENA needs to make a Series A investment to fund the company from the beginning of clinical development for 3 years. Vid SWISS Nordic Investor Meeting in Zurich, Switzerland organized by Business Sweden, we have had the opportunity to discuss Oncorena´s project with potential Swiss and other international investors. The purpose of the meeting has been fulfilled: We During the meeting, we met with a number of new potential investors and we will also have follow-up discussions
Approach and implementation
** Denna text är maskinöversatt ** ONCORENA needs to make a Series A investment to fund the company from the beginning of clinical development for 3 years. Vid SWISS Nordic Investor Meeting in Zurich, Switzerland organized by Business Sweden, we have had the opportunity to discuss Oncorena´s project with potential Swiss and other international investors. The purpose of the meeting has been fulfilled: We During the meeting, we met with a number of new potential investors and we will also have follow-up discussions